TrialDiabetes care2014

Efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes in a randomized controlled trial (AWARD-3).

Guillermo Umpierrez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.